Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synthesis and production of hydroxytyrosol derivatives with potent anti-inflammatory activities.

Created on 06 Jul 2026

Authors

Te-Sheng Chang, Wen-Yueh Ho, Jiumn-Yih Wu, Chien-Yu Wu, Pei-Rong Cai, Bo Eng Cheong, Wilson Thau Lym Yong, Peik Lin Teoh

Published in

Natural product research. Pages 1-9. Jul 05, 2026. Epub Jul 05, 2026.

Abstract

Hydroxytyrosol (HT) is a potent antioxidant compound abundantly found in various parts of olives. However, its high hydrophilicity hampers its formulation and delivery in nutraceutical and pharmaceutical applications. In this study, HT was chemically modified via esterification with benzoic acid derivatives to form HT-benzoate compounds. Sixteen HT derivatives (3a-3p) were produced with yields up to 72%. Structures were confirmed by NMR and HMRS analyses, and all compounds exhibited anti-inflammatory activity with nitric oxide inhibition. Among these, eight compounds showed anti-inflammatory activities with IC50 values of 3.46-5.95 μM, showing up to 10-fold increase compared to the precursor. All compounds were non-cytotoxic except compound 3d. Compounds 3a and 3l significantly suppressed the expression of key inflammatory genes such as tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin 6 (IL-6), and cyclooxygenase-2 (COX-2). These findings indicate that these HT derivatives may serve as promising anti-inflammatory candidates for further pharmacological evaluation.

PMID:
42402144
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement